Hims & Hers Health (NYSE:HIMS) Shares Up 1.6% - Still a Buy?

Shares of Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) shot up 1.6% during mid-day trading on Wednesday . The company traded as high as $52.33 and last traded at $49.74. 18,218,759 shares were traded during trading, a decline of 23% from the average session volume of 23,569,072 shares. The stock had previously closed at $48.96.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on HIMS. Truist Financial set a $45.00 price objective on shares of Hims & Hers Health in a research report on Tuesday, June 24th. Needham & Company LLC restated a "hold" rating on shares of Hims & Hers Health in a report on Monday, June 23rd. TD Cowen lowered shares of Hims & Hers Health from a "buy" rating to a "hold" rating and lowered their target price for the stock from $44.00 to $30.00 in a report on Tuesday, April 29th. UBS Group set a $30.00 target price on shares of Hims & Hers Health in a report on Monday, June 23rd. Finally, Wall Street Zen upgraded shares of Hims & Hers Health from a "hold" rating to a "buy" rating in a report on Sunday, June 15th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Hims & Hers Health has a consensus rating of "Hold" and a consensus target price of $39.58.

Hims & Hers Health Stock Performance

The company's 50 day moving average price is $53.26 and its 200-day moving average price is $40.67. The company has a market cap of $11.34 billion, a PE ratio of 73.47, a price-to-earnings-growth ratio of 1.80 and a beta of 2.02.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.08. Hims & Hers Health had a net margin of 9.24% and a return on equity of 22.75%. The company had revenue of $586.01 million during the quarter, compared to analyst estimates of $535.21 million. During the same quarter last year, the business posted $0.05 EPS. Hims & Hers Health's quarterly revenue was up 110.7% compared to the same quarter last year. Equities research analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Insider Buying and Selling at Hims & Hers Health

In related news, insider Michael Chi sold 17,102 shares of the firm's stock in a transaction that occurred on Tuesday, June 17th. The shares were sold at an average price of $59.75, for a total value of $1,021,844.50. Following the completion of the transaction, the insider directly owned 278,654 shares of the company's stock, valued at approximately $16,649,576.50. This trade represents a 5.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Oluyemi Okupe sold 23,107 shares of the firm's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $47.25, for a total transaction of $1,091,805.75. Following the completion of the transaction, the chief financial officer directly owned 63,222 shares of the company's stock, valued at approximately $2,987,239.50. The trade was a 26.77% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 670,250 shares of company stock valued at $34,487,591 in the last quarter. Corporate insiders own 13.71% of the company's stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Blume Capital Management Inc. raised its position in shares of Hims & Hers Health by 100.0% during the 4th quarter. Blume Capital Management Inc. now owns 1,200 shares of the company's stock valued at $29,000 after buying an additional 600 shares in the last quarter. Geneos Wealth Management Inc. purchased a new position in Hims & Hers Health in the 1st quarter worth $30,000. Smartleaf Asset Management LLC raised its position in Hims & Hers Health by 4,415.6% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the company's stock worth $36,000 after purchasing an additional 1,413 shares during the period. Summit Securities Group LLC purchased a new position in Hims & Hers Health in the 4th quarter worth $38,000. Finally, UMB Bank n.a. raised its position in Hims & Hers Health by 247.5% in the 1st quarter. UMB Bank n.a. now owns 1,310 shares of the company's stock worth $39,000 after purchasing an additional 933 shares during the period. 63.52% of the stock is owned by institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.